Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The key wish is Good Management. This company is poised to take off, I just it is by design and not some fortunate accident.
Nothing wrong with a mindless selloff when you have some more money to invest.
I would like a chance to add in the mid 3's
But only a temp pull back of course.
I think there is too much potential right now for this PPS to fall back below 4. So I have a decision to make.
This update belongs in the stickies. Thanks for taking the time.
It turns out it was a good time to wait for the drop and re-enter for me.
How have you been Mike?
Is there an update to any of these items?
Great List, BTW
From where we were last month this is just great.............
No need to consider tax loss selling for a while.
It would be interesting to know if he is short, and when and why he felt justified to short a low priced stock.
Overvalued? Why?
I agree that Barrons has been off the mark there was also a article bashing DLR that seems to have caused a disturbance.
I think the recent bull run has made investors overly cautious about any bad press and it is causing short term pullbacks. I look at the moves since jan 1st and know I overreacted to some 'bad' news and sold on a reactive dip, only to regret it later.
So I am holding line and lnco for now. Besides that 8% div is very nice.
Off and running this A.M. Where Too?
I was ready to pull the trigger this A.M. at $13.50.
What is going on?
The bottom is $0.00
Sounds Like Good News, Why the sell-Off?
$11.60 was a good buy Point
Now I need to pich a sell point.
I think 12.65 would be nice.
Everybody is buying the bargain stock
The $5.00 target is quite short of what some of us need...
So with the new stock ($12)sold...........
I went and bought at $11.60 today.
I think it is a good bottom.
But I have been wrong before...........
When will the $12 stock sell?
Or did it happen already?
New Article on CYTR
http://www.utsouthwestern.edu/utsw/cda/dept353744/files/639762.html
I care also
Holding on to more shares than I should be.
B.E. @ $1.25
Now you confused me
Did you read something more substancial?
MY read of the PR says;' we dumped this dog' maybe someday we will make some money back.
Just wait for the write offs on this one.
TWT.
DD before making bombastics moronic statements?
I read the release.
So how much money did they get, "as an a up-front payment" they neglected to mention. It reads to be to me as next to nothing since any substancial amount would be stated.
I bought a lottery ticket so I also 'could receive total payments of up to $120 million'
As I stated before there is no money yet and the whole thing depends on Orphazyme getting a breakthrough on the technology.
So NOBODY CARES in the investment community.
Up $0.02 this morning
NOBODY CARES
Up to $120 Million means nothing now...........
Notice they forgot to mention how much $ they got now.
no money down?
I saw the report.
Nothing there of substance.
Did I miss some hidden gem?
$4.00 Why?
This is a secret stock that can't get a break for the share holders.
We should be a $5.00 stock with proper P.R.
But they don't know how to sell the strengths of the product line to the public.
Once again the problem is not the business but the management.
Support is not the problem
The problem is the ceiling.
$1.00 looks like a barrier they can't break thru and stay above.
We Will Make Money on ISIS
It is just taking so damn long to get something.
It is a very well written PR
waiting long............
Can't Even get to a BUCK
So pathetic that even good news of a, fast track, protected drug can't get up some sustained interest.
AACR abstracts May be lighting up ISIS
http://www.abstractsonline.com/Plan/SSResults.aspx
Search abstracts for ISIS, if this does not work.
http://www.aacr.org/home/scientists/meetings--workshops/aacr-102nd-annual-meeting-2011.aspx
AACR abstracts seem to be lighting up IMGN
http://www.abstractsonline.com/Plan/SSResults.aspx
Search abstracts for IMMUNOGEN, if this does not work.
http://www.aacr.org/home/scientists/meetings--workshops/aacr-102nd-annual-meeting-2011.aspx
We must be the only ones
Holding this stock.
I moved some of it from my ira to my roth last year.
I hope to see a big jump before I have to pay the taxes in 11 & 12.
I thought buying it in the ira was a short term move.
It went down so I am married to it.
I know the strategy Well
we can hope. But I refuse to add more at any price.
I have owned this stock for years.
They turn often and it is the only way I made money on them.
I bought back in when it fell below 4 and I will sell out soon when they near 5.
Now that the genz/sny deal is done
When can we look forward to ISIS/sny plan being resolved?
I think there is still uncertainty about mipo.
Since the market hates uncertainty we will see isis in a 8.5 to 9.5 trading range.
Hope they resolve the issue, continue with mipo and let the fun begin for isis holders.
28.5 million shares outstanding
Traded almost them all today.
http://biz.yahoo.com/e/101229/xoma8-k.html
$7.30 is pre split $0.49
Long way to go for parity for some of us.
But something is better than where we were going.
cytr is confounding.
I have been trading them above and below a buck.
I expect to be caught one time when I sell above a buck by them finally putting out some real news.
But historically they have been disapointing to shareholders.
I am long again and that is why sale of rxii confounds and concerns me. They could put out some bad news and kick the legs out of the $1.00 stock.
Maybe they have a plan...................
posts on cytr
confused this AM
Something happened to our posts
Sec Filing Oct 30, 2007
RXi PHARMACEUTICALS CORPORATION
Shares of Common Stock
This prospectus is being furnished to the holders of common stock of CytRx Corporation, or CytRx, in connection with the distribution by CytRx to its stockholders of 4,526,624 outstanding shares of common stock of RXi Pharmaceuticals Corporation, or RXi, held by CytRx. The RXi shares being distributed under this prospectus will constitute approximately 36% of RXi's outstanding shares immediately following the distribution. Concurrently with the distribution, CytRx is awarding approximately 83,714 additional outstanding shares of RXi common stock held by CytRx to some of its directors, officers and employees. The award of RXi shares by CytRx is being made pursuant to a separate award prospectus dated the date of this prospectus. Immediately following the distributions made under this prospectus and the award made under the award prospectus, CytRx will own approximately 49% of the outstanding shares of RXi common stock, which shares are concurrently being registered for future resale by CytRx at such times and prices as it may choose pursuant to a separate resale prospectus also dated the date of this prospectus.
Happy New Year
Oct 30, 2007 SEC Filing, S-1 Registration.
Registration statement for face-amount certificate companies
RXi PHARMACEUTICALS CORPORATION
Shares of Common Stock
This prospectus is being furnished to the holders of common stock of CytRx Corporation, or CytRx, in connection with the distribution by CytRx to its stockholders of 4,526,624 outstanding shares of common stock of RXi Pharmaceuticals Corporation, or RXi, held by CytRx. The RXi shares being distributed under this prospectus will constitute approximately 36% of RXi's outstanding shares immediately following the distribution. Concurrently with the distribution, CytRx is awarding approximately 83,714 additional outstanding shares of RXi common stock held by CytRx to some of its directors, officers and employees. The award of RXi shares by CytRx is being made pursuant to a separate award prospectus dated the date of this prospectus. Immediately following the distributions made under this prospectus and the award made under the award prospectus, CytRx will own approximately 49% of the outstanding shares of RXi common stock, which shares are concurrently being registered for future resale by CytRx at such times and prices as it may choose pursuant to a separate resale prospectus also dated the date of this prospectus.
FYI
Cytr created & spun off rxii to cytr shareholders.
They had over 50% and sold it off in pieces.
It seems like they have not sold rxii at good prices.